Avara Pharmaceutical Services
↗Norman, Oklahoma, USA
Avara Pharmaceutical Services is a global Contract Development and Manufacturing Organization (CDMO) that provides clinical to commercial-scale drug product manufacturing, packaging, and technical services to the pharmaceutical industry. The company specializes in oral solid dosage (OSD) forms, including potent compounds, as well as sterile liquid and lyophilized fill-finish services.
Avara operates a network of facilities, many of which were acquired from large multinational pharmaceutical companies, allowing them to leverage established infrastructure and expertise. Their business model focuses on flexibility, client-centric partnerships, and supporting tech transfers and product launches for companies of all sizes.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:CDMO
Sub-Industry:Pharmaceutical Manufacturing and Packaging
SIZE & FINANCIALS
Ownership:private
Status:operating
FUNDING
Investors:American Industrial Acquisition Corporation (AIAC)
PIPELINE
Modalities:Small molecule, Sterile injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:American Industrial Acquisition Corporation (AIAC)
Key Partnerships:Serves various multinational pharmaceutical and venture-stage development companies.
COMPETITION
Position:Niche Player
Competitors:Alcami, TriRx Pharmaceutical Services, Lonza, Catalent
LINKS
Website:avara.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Avara Pharmaceutical Services and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Avara Pharmaceutical Services. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.